A citation-based method for searching scientific literature

W D Dupont, D L Page. N Engl J Med 1985
Times Cited: 1409

List of co-cited articles
522 articles co-cited >1

Times Cited
  Times     Co-cited

Benign breast disease and the risk of breast cancer.
Lynn C Hartmann, Thomas A Sellers, Marlene H Frost, Wilma L Lingle, Amy C Degnim, Karthik Ghosh, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, David W Hillman,[...]. N Engl J Med 2005

Atypical hyperplasia of the breast--risk assessment and management options.
Lynn C Hartmann, Amy C Degnim, Richard J Santen, William D Dupont, Karthik Ghosh. N Engl J Med 2015

Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
D L Page, W D Dupont, L W Rogers, M S Rados. Cancer 1985

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989

Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
Lynn C Hartmann, Derek C Radisky, Marlene H Frost, Richard J Santen, Robert A Vierkant, Lorelle L Benetti, Yaman Tarabishy, Karthik Ghosh, Daniel W Visscher, Amy C Degnim. Cancer Prev Res (Phila) 2014

Benign breast diseases: classification, diagnosis, and management.
Merih Guray, Aysegul A Sahin. Oncologist 2006

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Jeffrey A Tice, Diana L Miglioretti, Chin-Shang Li, Celine M Vachon, Charlotte C Gard, Karla Kerlikowske. J Clin Oncol 2015

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998

Breast cancer risk associated with benign breast disease: systematic review and meta-analysis.
Sara W Dyrstad, Yan Yan, Amy M Fowler, Graham A Colditz. Breast Cancer Res Treat 2015

Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
Amy C Degnim, Daniel W Visscher, Hal K Berman, Marlene H Frost, Thomas A Sellers, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, Piet C de Groen, Wilma L Lingle,[...]. J Clin Oncol 2007

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.
David L Page, Peggy A Schuyler, William D Dupont, Roy A Jensen, W Dale Plummer, Jean F Simpson. Lancet 2003

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
W D Dupont, F F Parl, W H Hartmann, L A Brinton, A C Winfield, J A Worrell, P A Schuyler, W D Plummer. Cancer 1993

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.
Amy C Degnim, William D Dupont, Derek C Radisky, Robert A Vierkant, Ryan D Frank, Marlene H Frost, Stacey J Winham, Melinda E Sanders, Jeffrey R Smith, David L Page,[...]. Cancer 2016

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
Valerie A McCormack, Isabel dos Santos Silva. Cancer Epidemiol Biomarkers Prev 2006

A prospective study of benign breast disease and the risk of breast cancer.
S J London, J L Connolly, S J Schnitt, G A Colditz. JAMA 1992

Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy.
Tehillah S Menes, Karla Kerlikowske, Jane Lange, Shabnam Jaffer, Robert Rosenberg, Diana L Miglioretti. JAMA Oncol 2017

Benign breast disorders.
Richard J Santen, Robert Mansel. N Engl J Med 2005

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.
Suzanne B Coopey, Emanuele Mazzola, Julliette M Buckley, John Sharko, Ahmet K Belli, Elizabeth M H Kim, Fernanda Polubriaginof, Giovanni Parmigiani, Judy E Garber, Barbara L Smith,[...]. Breast Cancer Res Treat 2012

Current management of lesions associated with an increased risk of breast cancer.
Monica Morrow, Stuart J Schnitt, Larry Norton. Nat Rev Clin Oncol 2015

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005

A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
Geoffrey C Kabat, Joan G Jones, Neal Olson, Abdissa Negassa, Catherine Duggan, Mindy Ginsberg, Rita A Kandel, Andrew G Glass, Thomas E Rohan. Cancer Causes Control 2010

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018

The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Laura C Collins, Heather J Baer, Rulla M Tamimi, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2006

Lower-category benign breast disease and the risk of invasive breast cancer.
Jiping Wang, Joseph P Costantino, Elizabeth Tan-Chiu, D Lawrence Wickerham, Soonmyung Paik, Norman Wolmark. J Natl Cancer Inst 2004

Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.
Laura C Collins, Heather J Baer, Rulla M Tamimi, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2007

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
Daniel W Visscher, Marlene H Frost, Lynn C Hartmann, Ryan D Frank, Robert A Vierkant, Ann E McCullough, Stacey J Winham, Celine M Vachon, Karthik Ghosh, Kathleen R Brandt,[...]. Cancer 2016

European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.
N Perry, M Broeders, C de Wolf, S Törnberg, R Holland, L von Karsa. Ann Oncol 2008

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015

Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.
Laura C Collins, Sarah A Aroner, James L Connolly, Graham A Colditz, Stuart J Schnitt, Rulla M Tamimi. Cancer 2016

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
Tari A King, Melissa Pilewskie, Shirin Muhsen, Sujata Patil, Starr K Mautner, Anna Park, Sabine Oskar, Elena Guerini-Rocco, Camilla Boafo, Jessica C Gooch,[...]. J Clin Oncol 2015

Diagnostic concordance among pathologists interpreting breast biopsy specimens.
Joann G Elmore, Gary M Longton, Patricia A Carney, Berta M Geller, Tracy Onega, Anna N A Tosteson, Heidi D Nelson, Margaret S Pepe, Kimberly H Allison, Stuart J Schnitt,[...]. JAMA 2015

Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.
Tehillah S Menes, Robert Rosenberg, Steven Balch, Shabnam Jaffer, Karla Kerlikowske, Diana L Miglioretti. Am J Surg 2014

Long-term risk of breast cancer in women with fibroadenoma.
W D Dupont, D L Page, F F Parl, C L Vnencak-Jones, W D Plummer, M S Rados, P A Schuyler. N Engl J Med 1994

Genome evolution during progression to breast cancer.
Daniel E Newburger, Dorna Kashef-Haghighi, Ziming Weng, Raheleh Salari, Robert T Sweeney, Alayne L Brunner, Shirley X Zhu, Xiangqian Guo, Sushama Varma, Megan L Troxell,[...]. Genome Res 2013

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, Elissa Bantug, Powel Brown, Nananda F Col, Jack Cuzick, Nancy E Davidson, Andrea Decensi, Carol Fabian, Leslie Ford,[...]. J Clin Oncol 2013

The molecular pathology of breast cancer progression.
Alessandro Bombonati, Dennis C Sgroi. J Pathol 2011

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
Xavier Castells, Laia Domingo, Josep María Corominas, Isabel Torá-Rocamora, María Jesús Quintana, Marisa Baré, Carmen Vidal, Carmen Natal, Mar Sánchez, Francina Saladié,[...]. Breast Cancer Res Treat 2015

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.
C L Carter, D K Corle, M S Micozzi, A Schatzkin, P R Taylor. Am J Epidemiol 1988

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.